60555-93-3

Basic information

• Product Name: 6-BROMO-2,3-DIMETHOXYBENZOIC ACID
• Synonyms: Benzoic acid, 6-bromo-2,3-dimethoxy-
• CAS NO: 60555-93-3
• Molecular Formula: C₉H₉BrO₄
• Molecular Weight: 261.07
• Mol File: 60555-93-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-BROMO-2,3-DIMETHOXYBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-2,3-DIMETHOXYBENZOIC ACID(60555-93-3)
• EPA Substance Registry System: 6-BROMO-2,3-DIMETHOXYBENZOIC ACID(60555-93-3)

Safety Data

• Hazardous Substances Data: 60555-93-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
6-Bromo-2,3-dimethoxybenzoic acid is utilized as a key intermediate in the synthesis of various bioactive compounds and pharmaceuticals. Its ability to alter the properties of other compounds makes it instrumental in creating new drugs with improved efficacy and safety profiles.
Used in Agrochemicals:
In the agrochemical industry, 6-Bromo-2,3-dimethoxybenzoic acid is employed for its potential to contribute to the development of new agrochemical products, enhancing crop protection and yield through its integration into chemical formulations.
Used in Materials Science:
6-Bromo-2,3-dimethoxybenzoic acid is also applied within the field of materials science, where it may be involved in the creation of novel materials with specific properties, such as improved stability or reactivity, depending on the application.
Used in Organic Synthesis:
As a building block in organic synthesis, 6-Bromo-2,3-dimethoxybenzoic acid is used to construct a diverse array of organic compounds for various applications, including but not limited to, the production of specialty chemicals, pharmaceuticals, and other high-value products.
Overall, 6-Bromo-2,3-dimethoxybenzoic acid's diverse range of uses in chemical research and production underscores its versatility and importance across multiple scientific and industrial domains.

Upstream product

• 77-48-5 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione 
• 1521-38-6 2,3-dimethoxybenzoic acid 
• 64482-27-5 2-bromo-5,6-dimethoxybenzoyl chloride 
• 83983-71-5 6-bromo-2,3-dihydroxybenzaldehyde 
• 20035-45-4 6-bromo-3-ethoxy-2-hydroxybenzaldehyde 
• 492-88-6 3-ethoxysalicylaldehyde 
• 7150-01-8 2-acetoxy-3-methoxybenzaldehyde 
• 20035-41-0 6-bromo-2-hydroxy-3-methoxybenzaldehyde 
• 53811-50-0 6-bromo-2,3-dimethoxybenzaldehyde 
• 5653-51-0 6-amino-2,3-dimethoxybenzoic acid 

Downstream Products

• 98260-81-2 N-(3-methoxy-6,7-methylenedioxynaphth-1-yl)-N-methylamide of 6-bromo-2,3-dimethoxybenzoic acid 
• 64482-27-5 2-bromo-5,6-dimethoxybenzoyl chloride 
• 3723-02-2 3,4-dimethoxyhomophthalic acid 
• 181634-59-3 6-Bromo-2,3-dimethoxy-N-(6,7-methylenedioxy-1-naphthyl)benzamide 
• 1521-38-6 2,3-dimethoxybenzoic acid 
• 59084-77-4 methyl 6-bromo-2,3-dimethoxybenzoate 
• 876189-26-3 6-bromo-N-(2,2-dimethoxyethyl)-2,3-dimethoxybenzamide 
• 876189-28-5 6-bromo-N-ethynyl-N-(2,2-dimethoxyethyl)-2,3-dimethoxybenzamide 
• 876189-27-4 6-bromo-N-(2,2-dimethoxyethyl)-2,3-dimethoxy-N-((trimethylsilyl)ethynyl)benzamide 
• 1027476-73-8 (5,6-dihydro-1,3-dioxa-7-aza-cyclohepta[f]inden-7-yl)-(2,3-dimethoxy-phenyl)-methanone 
• 385390-30-7 (6-bromo-2,3-dimethoxy-phenyl)-(5,6-dihydro-1,3-dioxa-7-aza-cyclohepta[f]inden-7-yl)-methanone 
• 385390-28-3 7-(6-bromo-2,3-dimethoxy-benzoyl)-6,7,8,9-tetrahydro-5H-1,3-dioxa-7-aza-cyclohepta[f]indene-6-carbaldehyde 
• 385390-29-4 N-(2-benzo[1,3]dioxol-5-yl-ethyl)-6-bromo-N-(2,2-dimethyl-4H-[1,3]dioxon-5-yl)-2,3-dimethoxy-benzamide 
• 28342-33-8 oxychelerythrine 

Relevant articles and documents

A short synthesis of lennoxamine via ynamides

Lennoxamine was synthesized in eight steps from 2,3-dimethoxybenzoic acid via an intermediate ynamide by using palladium-catalyzed Heck-Suzuki-Miyaura domino reactions.

Synthetic approaches to pallimamine and analogues using direct imine acylation

The use of Direct Imine Acylation (DIA) methodology for the total synthesis of pallimamine is described, with three different synthetic routes examined. The construction of three advanced δ-lactam precursors, all utilising DIA, is described, along with attempts to progress these compounds further, using three distinct desymmetrisation strategies, two involving alcohol-aryl coupling, and a third involving an unusual diastereoselective lactonisation.

Microwave-assisted domino hydroformylation/cyclization reactions: Scope and limitations

Hydroformylation of alkenes can be carried out in short time and with low syngas pressure under microwave (MW) dielectric heating. Alkenes, carrying O-, N-, or C-nucleophilic fragments, can be designed for domino reactions, mainly cyclocondensations. Ally

Synthesis of isoindolobenzazepine alkaloids based on radical reactions or Pd(0)-catalyzed reactions

(Chemical Equation Presented) Methods for synthesis of a ring system characteristic of isoindolobenzazepine alkaloids were studied. Synthesis of lennoxamine and a formal synthesis of chelenine were accomplished in a short route via radical or Pd(0)-cataly

Structure-activity relationship studies of phenanthridine-based Bcl-X L inhibitors

Despite their structural similarities, the natural products chelerythrine (5) and sanguinarine (6) target different binding sites on the pro-survival Bcl-XL protein. This paper details the synthesis of phenanthridine-based analogues of the natu

Synthesis of 3-(arylmethylene)isoindolin-1-ones from ynamides by Heck-Suzuki-Miyaura domino reactions. Application to the synthesis of lennoxamine

Substituted 3-(arylmethylene)isoindolin-1-ones can be efficiently synthesized from various ynamides and boronic acids by palladium-catalyzed Heck-Suzuki-Miyaura domino reactions. This methodology has been applied to the total synthesis of lennoxamine and a concise route to this isoindolobenzazepine alkaloid was achieved in eight steps from 2,3-dimethoxybenzoic acid via a key intermediate ynamide.

Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein

Compounds that are dual aP2/k-FABP inhibitors are provided having the formula wherein A, B, X, Y, R1, R2 and R3 are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing dual aP2/k-FABP inhibitors alone or in combination with at least one other antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.

Synthesis of (+/-)-8-Oxotetrahydropalmatine and (+/-)-Gusanlung B

The 8-oxotetrahydroprotoberberine alkaloids (+/-)-8-oxotetrahydropalmatine and (+/-)-gusanlung B have been synthesized by radical-initiated 1,6-cyclization of the corresponding 2-arylcarbonyl-1-methylenetetrahydroisoquinolines.

N-bromosuccinimide/dibromodimethylhydantoin in aqueous base: A practical method for the bromination of activated benzoic acids

A new bromination method employing NBS or dibromodimethylhydantoin in aqueous base is described for the synthesis of 3-bromo-2,6-dimethoxybenzoic acid (1) and other monobrominated alkoxybenzoic acids.

3-ETHOXY-2-HYDROXYBENZALDEHYDE AS A STARTING COMPOUND FOR SYNTHESIS OF ISOQUINOLINE ALKALOIDS

3-Ethoxy-2-hydroxybenzaldehyde (I) was used to prepare 6-bromo-2,3-dihydroxybenzaldehyde (V), 6-bromo-2,3-methylenedioxybenzaldehyde (VIa), 6-bromo-2,3-methylenedioxybenzoic acid (VIIa), and for new synthesis of compounds II, IIIa, IIIb, IV, VIb, VIIb, VIIIa, VIIIb, IXa and IXb.